Literature DB >> 8141126

A possible survival advantage in adults with acute leukemia receiving ABO-identical platelet transfusions.

J M Heal1, N Kenmotsu, J M Rowe, N Blumberg.   

Abstract

In a small cohort of leukemic patients participating in a randomized trial of ABO-identical vs. ABO-unmatched platelet transfusions, a statistically significant decrease in remission duration and increase in mortality were observed in patients receiving ABO-unmatched platelet transfusions. This difference was unexplained by previously described prognostic factors for remission duration and survival. Further study of this association is warranted.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8141126     DOI： 10.1002/ajh.2830450219

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


  8 in total

Review 1.  Platelet transfusions: impact on hemostasis, thrombosis, inflammation and clinical outcomes.

Authors:  Majed A Refaai; Richard P Phipps; Sherry L Spinelli; Neil Blumberg
Journal:  Thromb Res       Date:  2010-11-19       Impact factor: 3.944

2.  Platelet transfusion - the art and science of compromise.

Authors:  Joan Cid; Sarah K Harm; Mark H Yazer
Journal:  Transfus Med Hemother       Date:  2013-04-26       Impact factor: 3.747

3.  ABO matching of platelet transfusions - "Start Making Sense". "As we get older, and stop making sense…" - The Talking Heads (1984).

Authors:  Neil Blumberg; Majed Refaai; Joanna Heal
Journal:  Blood Transfus       Date:  2015-02-02       Impact factor: 3.443

4.  Transfusion of ABO non-identical platelets does not influence the clinical outcome of patients undergoing autologous haematopoietic stem cell transplantation.

Authors:  Pilar Solves; Nelly Carpio; Aitana Balaguer; Samuel Romero; Gloria Iacoboni; Inés Gómez; Ignacio Lorenzo; Federico Moscardó; Jaime Sanz; Francisca Lopez; Guillermo Martin; Isidro Jarque; Pau Montesinos; Javier De La Rubia; Guillermo Sanz; Miguel A Sanz
Journal:  Blood Transfus       Date:  2015-02-02       Impact factor: 3.443

5.  The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia.

Authors:  Darrell J Triulzi; Susan F Assmann; Ronald G Strauss; P M Ness; John R Hess; Richard M Kaufman; Suzanne Granger; Sherrill J Slichter
Journal:  Blood       Date:  2012-04-10       Impact factor: 22.113

6.  Lack of significant de novo HLA allosensitization in ventricular assist device recipients transfused with leukoreduced, ABO identical blood products.

Authors:  Myra Coppage; Marc Baker; Lawrence Fialkow; Danielle Meehan; Kelly Gettings; Leway Chen; H Todd Massey; Neil Blumberg
Journal:  Hum Immunol       Date:  2009-03-09       Impact factor: 2.850

Review 7.  A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.

Authors:  Gemma L Crighton; Lise J Estcourt; Erica M Wood; Marialena Trivella; Carolyn Doree; Simon Stanworth
Journal:  Cochrane Database Syst Rev       Date:  2015-09-30

8.  A randomized trial of washed red blood cell and platelet transfusions in adult acute leukemia [ISRCTN76536440].

Authors:  Neil Blumberg; Joanna M Heal; Jacob M Rowe
Journal:  BMC Blood Disord       Date:  2004-12-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.